These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1735613)

  • 21. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ.
    Pratheeshkumar P; Kuttan G
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):46-55. PubMed ID: 22176676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
    Suzuki T; Tahara H; Narula S; Moore KW; Robbins PD; Lotze MT
    J Exp Med; 1995 Aug; 182(2):477-86. PubMed ID: 7629507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
    Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
    Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
    J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.
    Bannerji R; Arroyo CD; Cordon-Cardo C; Gilboa E
    J Immunol; 1994 Mar; 152(5):2324-32. PubMed ID: 7907636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.
    Gazzinelli RT; Hieny S; Wynn TA; Wolf S; Sher A
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6115-9. PubMed ID: 8100999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells.
    Carson WE; Yu H; Dierksheide J; Pfeffer K; Bouchard P; Clark R; Durbin J; Baldwin AS; Peschon J; Johnson PR; Ku G; Baumann H; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4943-51. PubMed ID: 10202041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat-treated Lactobacillus plantarum increases the immune responses through activation of natural killer cells and macrophages on in vivo and in vitro models.
    Moon PD; Lee JS; Kim HY; Han NR; Kang I; Kim HM; Jeong HJ
    J Med Microbiol; 2019 Mar; 68(3):467-474. PubMed ID: 30724726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological transformation, tumorigenicity and src-specific cytotoxic T-lymphocyte-mediated tumor immunity induced by murine 3T3 cells expressing src oncogenes encoding novel non-myristylated N-terminal domains.
    Gelman IH; Khan S; Hanafusa H
    Oncogene; 1993 Nov; 8(11):2995-3004. PubMed ID: 7692370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
    Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
    Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Aoki T; Asano T; Ochiai T; Isono K; Kageyama H; Nakamura Y; Sakiyama S
    Int J Cancer; 1996 Mar; 66(1):135-9. PubMed ID: 8608957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between T cells and innate immune cells is crucial for IFN-gamma-dependent tumor rejection.
    Li Z; Pradera F; Kammertoens T; Li B; Liu S; Qin Z
    J Immunol; 2007 Aug; 179(3):1568-76. PubMed ID: 17641023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells.
    Davies E; Reid S; Medina MF; Lichty B; Ashkar AA
    J Leukoc Biol; 2010 Sep; 88(3):529-36. PubMed ID: 20538758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.